A Novel Small Molecule Which Increases Osteoprotegerin Expression and Protects Against Ovariectomy-Related Bone Loss in Rats

The ratio of osteoprotegerin (OPG) to the receptor activator of NF-κB ligand (RANKL) is a key determinant in the regulation of bone metabolism. The study was performed to screen novel anti-osteoporotic drugs regulating OPG/RANKL ratio and evaluate their effect on bone metabolism. According to the sc...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Xiaowan, Gong, Shiqiang, Li, Ni, Wang, Xiao, Liu, Peng, Xu, Yanni, He, Xiaobo, Jiang, Wei, Si, Shuyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6421503/
https://www.ncbi.nlm.nih.gov/pubmed/30914947
http://dx.doi.org/10.3389/fphar.2019.00103

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6421503/
https://www.ncbi.nlm.nih.gov/pubmed/30914947
http://dx.doi.org/10.3389/fphar.2019.00103

Ejemplares similares